Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

NCT01243177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

888

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Monotherapy

Interventions

DRUG: Lacosamide
DRUG: Carbamazepine-Controlled Release

Sponsor

UCB BIOSCIENCES GmbH

Collaborators

[object Object]